BioCentury
ARTICLE | Distillery Techniques

Imaging

January 29, 2019 1:52 PM UTC

An MMP14-targeting PET imaging agent could help diagnose MMP14-overexpressing fibrosarcoma and other cancers. The agent consists of an MMP14-binding bicyclic peptide conjugated to tetraazacyclododecan...

BCIQ Company Profiles

Bicycle Therapeutics plc